Heart Transplant Market Trends Reshaping Industry Growth Through 2030

Heart Transplant Market Report

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Heart Transplant Market Revenue Growth On Track For A 9.9% CAGR Through 2030

The heart transplant market has experienced substantial expansion in recent years. It is projected to grow from $12.62 billion in 2025 to $13.77 billion in 2026, at a compound annual growth rate (CAGR) of 9.1%. Historically, this growth can be attributed to factors such as the increasing prevalence of end-stage heart failure, the expansion of cardiac specialty centers, enhancements in surgical techniques, the growing availability of transplant programs, and the rising use of mechanical circulatory support.

The heart transplant market size is projected to experience substantial growth in the coming years, reaching $20.08 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.9%. This expansion is primarily driven by factors such as increasing investments in artificial heart research, a rising demand for long-term cardiac support solutions, the expansion of donor management technologies, a growing focus on precision post-transplant care, and the increasing adoption of digital health monitoring. Furthermore, significant trends expected during the forecast period include the increasing adoption of ventricular assist devices, the rising use of advanced transplant monitoring systems, the growing integration of digital patient management platforms, the expansion of artificial heart technologies, and an enhanced focus on post-transplant outcomes.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=54718312&type=smp&name=Heart%20Transplant%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Heart Transplant Market Growth Drivers: What’s Behind The Acceleration?

The anticipated increase in cardiovascular diseases is projected to drive the expansion of the heart transplant market in the future. These diseases encompass various conditions impacting the heart and blood vessels. A heart transplant serves as a final therapeutic option for individuals suffering from end-stage heart failure, especially when alternative treatments have proven ineffective. This procedure enhances the quality of life and prolongs survival. As an illustration, data from September 2024, provided by the British Heart Foundation, a cardiovascular research charity based in the UK, indicates that around 7.6 million people in the UK are presently living with heart and circulatory conditions, with this figure split between 4 million men and 3.6 million women. Projections suggest this number could climb by 1 million by 2030, potentially reaching an additional 2 million above current totals by 2040. Consequently, the widespread occurrence of cardiovascular diseases is set to be a key driver for the heart transplant market.

Heart Transplant Market Segment Breakdown: Which Categories Lead On Revenue?

The heart transplant market covered in this report is segmented –

1) By Transplant Procedure Type: Orthotopic Heart Transplant, Heterotopic Heart Transplant

2) By Donor Type: Allograft, Extended-Criteria Donor Hearts

3) By Indication: End-Stage Heart Failure, Ischemic Cardiomyopathy, Dilated Cardiomyopathy, Congenital Heart Disease, Valvular Heart Disease, Other Severe Cardiac Disorders

4) By Recipient Age Group: Pediatric Patients, Adult Patients, Geriatric Patients

5) By End User: Hospitals, Specialized Cardiac Transplant Centers, Academic & Research Institutes

Subsegments:

1) By Orthotopic Heart Transplant: Standard Orthotopic Heart Transplant, Donation After Brain Death (DBD) Orthotopic Transplant, Donation After Circulatory Death (DCD) Orthotopic Transplant, ABO-Compatible Orthotopic Transplant

2) By Heterotopic Heart Transplant (HHT): Left Heterotopic Heart Transplant, Right Heterotopic Heart Transplant, Biventricular Heterotopic Heart Transplant, Bridge-to-Recovery Heterotopic Transplant

Heart Transplant Market Trends Redefining Industry Growth

Major companies in the heart transplant market are increasingly concentrating on crafting innovative solutions, such as heart preservation technology, to elevate patient outcomes and boost transplant success rates. This technology notably extends the duration a heart can be preserved outside the body compared to conventional ice storage, thereby yielding improved results and diminishing complications post-transplantation. Illustratively, in May 2023, Xvivo Perfusion AB, a medical technology firm based in Sweden, received approval from the U.S. Food and Drug Administration (FDA) for an Investigational Device Exemption (IDE) application concerning its heart preservation technology, paving the way for the initiation of the ‘PRESERVE Clinical Trial.’ This trial is structured as a prospective, multicenter, single-arm, open-label study, focused on evaluating hearts transplanted following non-ischemic heart preservation obtained from extended donors, specifically encompassing Donation after Circulatory Death (DCD) hearts. A key distinguishing characteristic of XVIVO’s heart preservation technology is its non-ischemic hypothermic perfusion system, which utilizes cold, oxygenated perfusion for the preservation of donor hearts during transportation.

Heart Transplant Market Leading Players And Competitive Positioning

Major companies operating in the heart transplant market are Mayo Clinic, Cleveland Clinic, Massachusetts General Hospital, Johns Hopkins Hospital, NewYork-Presbyterian Hospital, Cedars-Sinai Medical Center, Stanford Health Care, Baylor St Lukes Medical Center, The Texas Heart Institute, Duke University Hospital, UCLA Medical Center, Mount Sinai Hospital, Brigham and Womens Hospital, University of Pittsburgh Medical Center, Houston Methodist Hospital, Northwestern Memorial Hospital, NYU Langone Health, Toronto General Hospital, Royal Papworth Hospital, Harefield Hospital

View The Full Heart Transplant Market Report:

https://thebusinessresearchcompany.com/report/heart-transplant-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Heart Transplant Market Top Region: Where Does Most Revenue Come From?

North America was the largest region in the heart transplant market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart transplant market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model